With the emergence of generative AI in entertainment media, the right of publicity in relation to actors’ likeness is becoming increasingly prevalent. Modifying voices using generative AI (“genAI”) has become a serious concern amongst voice actors, and it is important to examine whether voices are a part of identity protected by public use law.

The high cost of medicine affords wealthier people a better opportunity for health than others. The recent “trend” of using Ozempic and other GLP-1 medications for weight loss highlighted this disparity. To prevent increasing costs, should pharmacies and physicians be allowed to compound ingredients of patented drugs owned by pharmaceutical companies even when there is no drug shortage?